By the end of this chapter you'll be able to…

  • 1Use the level of the split to predict blister appearance, Nikolsky sign and prognosis
  • 2Distinguish desmosomal from hemidesmosomal targets and their consequences
  • 3Explain desmoglein compensation and use it to predict site of blistering
  • 4Explain why pemphigus foliaceus spares mucosa and vulgaris begins in the mouth
  • 5Describe the suprabasal split and the tombstone appearance
  • 6Elicit and interpret the Nikolsky and Asboe-Hansen signs
  • 7State why direct immunofluorescence is taken from perilesional skin
  • 8Recognise paraneoplastic pemphigus and its associations
  • 9State the current first-line treatment of pemphigus vulgaris and the evidence for it
  • 10Describe bullous pemphigoid including its prodromal phase
  • 11State the drug class most associated with bullous pemphigoid and its Indian relevance
  • 12Distinguish the major subepidermal diseases by antigen and clinical feature
  • 13Explain why mucous membrane pemphigoid demands ophthalmological review
  • 14Recognise dermatitis herpetiformis and separate its two treatment components
  • 15Interpret direct immunofluorescence patterns across the group
  • 16Explain how salt-split skin separates pemphigoid from epidermolysis bullosa acquisita
  • 17Apply three principles governing treatment intensity across the group
  • 18Distinguish toxic epidermal necrolysis from pemphigus despite a shared sign
  • 19Explain why staphylococcal scalded skin syndrome mimics pemphigus foliaceus
  • 20Approach blistering in a child by age of onset and distribution
💡
Why this chapter matters in NEET PG
Blistering diseases look like a list of names attached to antibodies, and memorised that way they are almost impossible to hold. One question converts the whole group into a single reasoning exercise: at what level does the skin split? Depth determines the blister's appearance, the Nikolsky sign, whether mucosa is involved, the age of the patient and the untreated prognosis. A second idea, desmoglein compensation, explains why one antibody blisters mucosa and another blisters only skin. Clinically the stakes are high: untreated pemphigus was fatal, rituximab has recently displaced high-dose steroid as first-line therapy, and in India a very large number of elderly diabetics take gliptins, the drug class most strongly associated with bullous pemphigoid.

Immunobullous Disorders

Blistering diseases look like a list of names attached to antibodies. They become a single reasoning exercise once you ask one question.

At what level does the skin split?

The epidermis is held together by desmosomes between keratinocytes, and it is anchored to the dermis by hemidesmosomes at the basement membrane zone. Autoantibodies against the first group split the epidermis internally; autoantibodies against the second group lift the whole epidermis off the dermis.

Everything clinically observable follows from that depth.

FeatureIntraepidermal splitSubepidermal split
PrototypePemphigusPemphigoid
Blister roofA few cell layers, fragileFull-thickness epidermis, tough
Blister appearanceFlaccid, ruptures easily, erosionsTense, intact, may be haemorrhagic
Nikolsky signPositiveNegative
MucosaCommonly involvedUsually spared
AgeMiddle ageElderly
Prognosis untreatedFatalChronic, self-limiting over years

A second idea explains the rest: which antigen is targeted determines which body site is affected, because the anchoring proteins are not distributed evenly.

1. Desmoglein Compensation

Pemphigus antibodies target desmogleins, the transmembrane adhesion proteins of desmosomes. Two matter.

Desmoglein 3 is expressed throughout mucosal epithelium but only in the deeper epidermis of skin. Desmoglein 1 is expressed throughout the epidermis, most strongly superficially, and only weakly in mucosa.

Where both are present, one can compensate for the loss of the other. That single fact predicts the entire clinical picture.

Antibody profileMucosaSkinDisease
Anti-Dsg3 onlyBlisters, since Dsg1 is too weak to compensateIntact, since Dsg1 compensatesMucosal-dominant pemphigus vulgaris
Anti-Dsg3 and anti-Dsg1BlistersBlistersMucocutaneous pemphigus vulgaris
Anti-Dsg1 onlyIntact, since Dsg3 compensatesSuperficial blistersPemphigus foliaceus

This is why pemphigus foliaceus never involves mucosa and why pemphigus vulgaris almost always begins in the mouth, often months before any skin lesion.

It also explains the depth of the split. Pemphigus vulgaris splits suprabasally, just above the basal layer where Dsg3 lives, leaving a characteristic row of basal cells still attached to the dermis, described as a tombstone appearance. Pemphigus foliaceus splits high, in the subcorneal layer.

2. Pemphigus

Pemphigus vulgaris typically presents in middle age with painful oral erosions that will not heal, and intact blisters are rarely seen because they rupture almost immediately.

Nikolsky sign is the shearing off of apparently normal skin under firm lateral pressure, indicating acantholysis in surrounding clinically uninvolved skin. Bulla spread sign, or Asboe-Hansen sign, is the extension of an existing blister when pressure is applied to its top.

Histology shows acantholysis with a suprabasal split. Direct immunofluorescence shows intercellular IgG and C3 in a fishnet or chicken-wire pattern around keratinocytes.

Direct immunofluorescence is performed on perilesional skin, not on the blister itself, since the roof has already separated and the immunoreactants are lost.

Variants worth separating

Pemphigus foliaceus produces scaly crusted erosions on seborrhoeic areas with no mucosal disease, and its endemic form is fogo selvagem in Brazil.

Paraneoplastic pemphigus is the one that must not be missed. It presents with severe intractable stomatitis often with lichenoid skin lesions, associates with lymphoproliferative disease including chronic lymphocytic leukaemia and Castleman disease, and can involve respiratory epithelium producing bronchiolitis obliterans, which is the usual cause of death.

IgA pemphigus shows intercellular IgA rather than IgG and behaves more like a neutrophilic dermatosis.

Treatment

Rituximab has moved to first-line therapy in pemphigus vulgaris, and this is the most important change in the subject.

The Ritux 3 trial showed rituximab combined with short-term prednisolone to be superior to prednisolone alone, and long-term follow-up published subsequently reported sustained corticosteroid-free remission in a substantial proportion of first-line patients.

The mechanism fits the disease exactly: pemphigus is a B-cell-driven autoantibody disease, and depleting CD20-positive B cells removes the source of the antibody rather than merely suppressing inflammation.

The practical gain is steroid sparing. Conventional treatment required prolonged high-dose corticosteroid with its full burden of diabetes, osteoporosis, infection and myopathy, and first-line rituximab reduces both cumulative steroid dose and adverse events.

3. Bullous Pemphigoid

Bullous pemphigoid is the commonest autoimmune blistering disease, and it is a disease of the elderly.

Antibodies target BP180, also called collagen XVII, and BP230, both components of the hemidesmosome. BP180 is transmembrane and is the pathogenically important one; BP230 is intracellular.

The split is therefore below the entire epidermis, so the blister roof is full-thickness skin. Blisters are tense, often large, sometimes haemorrhagic, and they persist for days. Nikolsky sign is negative.

A prodromal phase of intense itch with urticarial or eczematous plaques, sometimes lasting weeks or months before any blister appears, is common and frequently misdiagnosed.

Direct immunofluorescence shows linear IgG and C3 along the basement membrane zone, the linear pattern contrasting with the fishnet of pemphigus.

Mucosal involvement is uncommon and mild, and untreated disease is chronic and often self-limiting over years rather than fatal, which is why treatment can be less aggressive than in pemphigus. Potent topical corticosteroid is effective in localised disease and, in trial data, compares well with systemic steroid.

The drug association that matters in India

Dipeptidyl peptidase-4 inhibitors, the gliptins, carry the highest drug-associated risk of bullous pemphigoid of any drug class, with vildagliptin most strongly implicated.

This matters disproportionately in India, where gliptins are very widely prescribed for type 2 diabetes. The drug-associated cases often show a non-inflammatory phenotype with less erythema, and they target different BP180 epitopes.

Any elderly diabetic on a gliptin who develops itch or blisters should have the drug reviewed, since withdrawal alone can lead to resolution.

4. The Other Subepidermal Diseases

DiseaseAntigenDistinguishing feature
Mucous membrane pemphigoidBP180, laminin 332Scarring; ocular symblepharon and blindness
Pemphigoid gestationisBP180Third trimester, starts periumbilically
Dermatitis herpetiformisEpidermal transglutaminaseIntensely itchy grouped vesicles on extensors
Linear IgA diseaseLAD-1String of pearls; vancomycin-induced in adults
Epidermolysis bullosa acquisitaType VII collagenTrauma-prone sites, scarring, milia

Mucous membrane pemphigoid scars, and that single word governs its management. Conjunctival involvement produces symblepharon, entropion, trichiasis and eventually blindness, so ophthalmological review is mandatory rather than optional.

Pemphigoid gestationis begins periumbilically in the third trimester, may flare at delivery, and can produce transient blistering in the neonate through transplacental antibody.

Dermatitis herpetiformis is the skin expression of coeliac disease. The itch is severe and the vesicles are usually excoriated before they are seen. Direct immunofluorescence shows granular IgA in the dermal papillae, distinguishing it from the linear IgA of linear IgA disease.

Dapsone produces dramatic symptomatic relief within days, but a gluten-free diet is the treatment of the underlying disease and is what controls the enteropathy and the long-term lymphoma risk.

5. Making the Diagnosis

Three investigations answer different questions, and confusing them is a common error.

Histopathology from an intact early blister shows the level of the split and whether acantholysis is present.

Direct immunofluorescence on perilesional skin shows what antibody is deposited and in what pattern: fishnet intercellular IgG in pemphigus, linear IgG and C3 at the basement membrane in pemphigoid, granular IgA in dermal papillae in dermatitis herpetiformis.

Indirect immunofluorescence and ELISA on serum detect circulating antibody and, importantly, titres correlate with disease activity in pemphigus, so they are used to monitor treatment and predict relapse.

Salt-split skin separates the subepidermal diseases from one another. Incubating skin in sodium chloride splits it through the lamina lucida, and the antibody then localises either to the roof, indicating BP180 or BP230 in bullous pemphigoid, or to the floor, indicating type VII collagen in epidermolysis bullosa acquisita.

The elegance of the salt-split technique is that it uses the disease's own logic: if the antibody target lies above the lamina lucida it travels with the roof, and if it lies below it stays with the floor. The clinical distinction matters because epidermolysis bullosa acquisita responds poorly to the treatment that controls pemphigoid.

6. Principles of Treatment

Three ideas govern treatment across the group, and they are more useful than any drug list.

Match the aggression of treatment to the natural history. Untreated pemphigus was fatal, so it justifies immunosuppression that carries real risk. Bullous pemphigoid is chronic and often remits over years, so potent topical corticosteroid alone is frequently sufficient and compares well with systemic steroid in trial data.

Remove the source rather than suppressing the effect where possible. Rituximab depletes the CD20-positive B cells producing the autoantibody, which is why it produces durable remission rather than requiring indefinite suppression. This is the reasoning behind its move to first-line use in pemphigus.

Look for a trigger before committing to long-term immunosuppression. Gliptins in bullous pemphigoid, vancomycin in linear IgA disease, and gluten in dermatitis herpetiformis are all removable causes, and removing them can make immunosuppression unnecessary.

The unglamorous parts that decide outcome

Denuded skin loses fluid, protein and heat and admits bacteria, so the mortality in severe pemphigus historically came from sepsis and metabolic disturbance rather than from the blisters themselves.

Oral erosions prevent eating, so nutritional support and analgesia are treatment rather than comfort measures. Ocular involvement in mucous membrane pemphigoid needs a specialist reviewing the eye, because scarring is silent and irreversible.

And every patient on prolonged corticosteroid needs bone protection, glycaemic monitoring and consideration of prophylaxis against opportunistic infection, which in India includes screening for latent tuberculosis and for strongyloidiasis before immunosuppression.

7. What Else Blisters

Two non-immunobullous conditions must be excluded because their management is entirely different.

Stevens-Johnson syndrome and toxic epidermal necrolysis are drug reactions with full-thickness epidermal necrosis. They have a positive Nikolsky sign, which is why they are confused with pemphigus, but the onset is acute over days, there is prominent mucosal and ocular involvement, and the histology shows necrosis rather than acantholysis.

Staphylococcal scalded skin syndrome results from exfoliative toxin cleaving desmoglein 1, which is why it produces a superficial subcorneal split identical in level to pemphigus foliaceus. It spares mucosa for exactly the same reason: desmoglein 3 compensates there.

That last point is a rare instance of a toxin and an autoantibody producing an identical clinical picture through the same molecular target.

Blistering in children

Three additional possibilities dominate paediatric practice and are separated on distribution and immunofluorescence.

Chronic bullous disease of childhood is linear IgA disease presenting before puberty. New blisters form at the edge of resolving annular lesions, producing the string of pearls or cluster of jewels appearance, typically around the perineum and lower trunk. Direct immunofluorescence shows linear IgA, and dapsone is effective.

Hereditary epidermolysis bullosa is a group of genetic defects in structural proteins, not an autoimmune disease, so immunofluorescence for autoantibodies is negative. Blistering follows minor friction from birth, and the level of the defect determines severity: simplex within the basal keratinocyte, junctional within the lamina lucida, and dystrophic below it in type VII collagen, which is the form that scars and fuses digits.

Bullous impetigo is localised staphylococcal disease producing flaccid blisters with a collarette of scale, and it shares its mechanism with staphylococcal scalded skin syndrome.

The practical rule is that blistering from birth or early infancy with a family history is genetic until proved otherwise, and blistering appearing later in an otherwise well child is more likely infective or immunobullous.

8. Worked Examples

Example 1. A 48-year-old has six weeks of painful oral erosions and now flaccid blisters on the trunk that rupture leaving raw areas. Firm lateral pressure on normal-looking skin shears the epidermis away. What is the diagnosis and which investigations confirm it?

Pemphigus vulgaris. Painful oral erosions preceding skin disease, flaccid blisters and a positive Nikolsky sign all indicate an intraepidermal split with acantholysis extending into clinically normal skin.

Confirm with three tests answering different questions. Histopathology of an intact early blister shows a suprabasal split with a tombstone row of retained basal cells. Direct immunofluorescence on perilesional skin shows intercellular IgG and C3 in a fishnet pattern. Serum ELISA detects anti-desmoglein 3 with or without anti-desmoglein 1, and the titre can then be used to monitor activity.

Example 2. A 78-year-old diabetic on vildagliptin has three months of intense itch with urticarial plaques, and now tense blisters on the limbs that remain intact for days. Nikolsky sign is negative. What is the diagnosis and what specific action is required?

Bullous pemphigoid. Tense blisters with a negative Nikolsky sign indicate a subepidermal split, and the long prodrome of itch and urticarial plaques before blistering is characteristic and often misdiagnosed as eczema.

The specific action is to review the vildagliptin. Dipeptidyl peptidase-4 inhibitors carry the highest drug-associated risk of bullous pemphigoid of any class, vildagliptin most strongly, and this is of particular importance in India where gliptins are heavily prescribed. Withdrawal of the drug, with substitution of an alternative agent, can lead to resolution and should be arranged alongside treatment with potent topical or systemic corticosteroid.

Example 3. Explain why pemphigus foliaceus never involves the mouth while pemphigus vulgaris almost always starts there.

Desmoglein compensation. Desmoglein 3 is expressed throughout mucosal epithelium but only in the deeper epidermis, while desmoglein 1 is expressed throughout the epidermis, most strongly superficially, and only weakly in mucosa.

Pemphigus foliaceus antibodies target desmoglein 1 alone. In skin, the superficial epidermis depends on desmoglein 1 with little desmoglein 3 to compensate, so it splits subcorneally. In mucosa, abundant desmoglein 3 compensates fully for the loss of the little desmoglein 1 present, so the mucosa remains intact.

Pemphigus vulgaris antibodies target desmoglein 3. In mucosa there is too little desmoglein 1 to compensate, so blistering occurs. In skin, desmoglein 1 compensates superficially, which is why mucosal-dominant disease can exist with entirely normal skin until anti-desmoglein 1 antibodies also develop.

Example 4. A 30-year-old has intensely itchy grouped vesicles on the elbows, knees and buttocks, mostly excoriated. What is the diagnosis, which immunofluorescence pattern confirms it, and what are the two components of treatment?

Dermatitis herpetiformis, the cutaneous expression of gluten sensitivity. The distribution on extensor surfaces and buttocks with severe itch is characteristic, and intact vesicles are often absent because they are scratched away.

Direct immunofluorescence on perilesional skin shows granular IgA deposits in the dermal papillae, which distinguishes it from linear IgA disease where the deposition is linear along the basement membrane.

Treatment has two separate components. Dapsone controls symptoms dramatically within days but does nothing for the enteropathy. A strict gluten-free diet treats the underlying coeliac disease, is what allows dapsone to be withdrawn eventually, and addresses the long-term risk of small bowel lymphoma.

Example 5. A patient with a blistering disease has a positive Nikolsky sign, extensive mucosal ulceration and skin detachment, and became unwell over four days after starting a new drug. Why is this probably not pemphigus?

Because the tempo and the trigger are wrong. Pemphigus develops over weeks to months, characteristically beginning with oral erosions that persist and only later producing skin blisters. Onset over four days following a new drug points strongly to toxic epidermal necrolysis.

The Nikolsky sign is positive in both, which is exactly why they are confused, but the mechanism differs. In pemphigus the epidermis splits internally through acantholysis, whereas in toxic epidermal necrolysis the full thickness of the epidermis undergoes necrosis and detaches at the dermo-epidermal junction.

Histology separates them decisively, showing acantholysis in one and full-thickness keratinocyte necrosis in the other. Management differs completely: immediate withdrawal of the culprit drug and supportive care in a burns or high-dependency setting, rather than immunosuppression.

Summary

Ask at what level the skin splits; everything else follows.

Intraepidermal split gives flaccid blisters, positive Nikolsky, mucosal disease and a worse prognosis.

Subepidermal split gives tense blisters, negative Nikolsky and usually spared mucosa.

Desmoglein 3 dominates mucosa; desmoglein 1 dominates superficial skin.

Compensation explains why foliaceus spares mucosa and vulgaris begins in the mouth.

Pemphigus vulgaris splits suprabasally, leaving a tombstone row of basal cells.

Direct immunofluorescence shows fishnet intercellular IgG in pemphigus.

Perilesional skin, not the blister, is sampled for immunofluorescence.

Paraneoplastic pemphigus associates with lymphoproliferative disease and can cause bronchiolitis obliterans.

Rituximab is now first-line in pemphigus vulgaris, on the Ritux 3 trial and its follow-up.

Bullous pemphigoid targets BP180 and BP230 and affects the elderly.

Pemphigoid shows linear IgG and C3 at the basement membrane zone.

An itchy urticarial prodrome can precede pemphigoid blisters by months.

Gliptins, especially vildagliptin, carry the highest drug-associated risk of pemphigoid.

Mucous membrane pemphigoid scars and can blind through symblepharon.

Pemphigoid gestationis starts periumbilically in the third trimester.

Dermatitis herpetiformis shows granular IgA in dermal papillae and responds to dapsone.

A gluten-free diet, not dapsone, treats the underlying coeliac disease.

Salt-split skin puts pemphigoid antibody on the roof and EBA antibody on the floor.

Toxic epidermal necrolysis also has a positive Nikolsky sign but shows necrosis, not acantholysis.

Staphylococcal scalded skin syndrome cleaves desmoglein 1, mimicking pemphigus foliaceus exactly.

Key formulas & results

Everything to memorise for the exam hall, in one card. Screenshot this for revision.

The organising tool
ASK AT WHAT LEVEL THE SKIN SPLITS. EVERYTHING CLINICALLY OBSERVABLE FOLLOWS FROM THAT DEPTH.
AUTOANTIBODIES AGAINST DESMOSOMES SPLIT THE EPIDERMIS INTERNALLY. AUTOANTIBODIES AGAINST HEMIDESMOSOMES LIFT THE WHOLE EPIDERMIS OFF THE DERMIS.
The two columns
INTRAEPIDERMAL: FLACCID BLISTERS, POSITIVE NIKOLSKY, MUCOSA INVOLVED, MIDDLE AGE, FATAL UNTREATED. SUBEPIDERMAL: TENSE BLISTERS, NEGATIVE NIKOLSKY, MUCOSA SPARED, ELDERLY, CHRONIC AND SELF-LIMITING.
THE BLISTER ROOF IS A FEW CELL LAYERS IN ONE AND FULL-THICKNESS EPIDERMIS IN THE OTHER, WHICH IS WHY ONE RUPTURES INSTANTLY AND THE OTHER PERSISTS FOR DAYS.
Desmoglein distribution
DSG3 IS EXPRESSED THROUGHOUT MUCOSAL EPITHELIUM BUT ONLY IN DEEPER EPIDERMIS. DSG1 IS EXPRESSED THROUGHOUT EPIDERMIS, STRONGEST SUPERFICIALLY, AND ONLY WEAKLY IN MUCOSA.
WHERE BOTH ARE PRESENT, ONE COMPENSATES FOR LOSS OF THE OTHER. THIS SINGLE FACT PREDICTS THE ENTIRE CLINICAL DISTRIBUTION OF PEMPHIGUS.
Compensation predicts the disease
ANTI-DSG3 ALONE GIVES MUCOSAL-DOMINANT PEMPHIGUS VULGARIS. ANTI-DSG3 PLUS ANTI-DSG1 GIVES MUCOCUTANEOUS DISEASE. ANTI-DSG1 ALONE GIVES PEMPHIGUS FOLIACEUS WITH NO MUCOSAL INVOLVEMENT.
THIS IS WHY FOLIACEUS NEVER INVOLVES MUCOSA AND WHY VULGARIS ALMOST ALWAYS BEGINS IN THE MOUTH, OFTEN MONTHS BEFORE ANY SKIN LESION.
Level of the pemphigus split
PEMPHIGUS VULGARIS SPLITS SUPRABASALLY, JUST ABOVE THE BASAL LAYER WHERE DSG3 LIVES, LEAVING A TOMBSTONE ROW OF BASAL CELLS. PEMPHIGUS FOLIACEUS SPLITS SUBCORNEALLY.
THE HISTOLOGICAL LEVEL IS PREDICTED DIRECTLY BY WHERE THE TARGET PROTEIN IS MOST CONCENTRATED.
The two pressure signs
NIKOLSKY SIGN IS SHEARING OF APPARENTLY NORMAL SKIN UNDER FIRM LATERAL PRESSURE. ASBOE-HANSEN OR BULLA SPREAD SIGN IS EXTENSION OF AN EXISTING BLISTER WHEN PRESSURE IS APPLIED TO ITS TOP.
A POSITIVE NIKOLSKY MEANS ACANTHOLYSIS EXTENDS INTO CLINICALLY UNINVOLVED SKIN, WHICH IS WHY THE DISEASE IS MORE EXTENSIVE THAN IT LOOKS.
Where to biopsy
HISTOPATHOLOGY FROM AN INTACT EARLY BLISTER. DIRECT IMMUNOFLUORESCENCE FROM PERILESIONAL SKIN, NEVER FROM THE BLISTER ITSELF.
THE BLISTER ROOF HAS ALREADY SEPARATED AND ITS IMMUNOREACTANTS ARE LOST, SO SAMPLING IT PRODUCES A FALSE NEGATIVE.
Immunofluorescence patterns
FISHNET INTERCELLULAR IGG AND C3 IN PEMPHIGUS. LINEAR IGG AND C3 AT THE BASEMENT MEMBRANE IN PEMPHIGOID. GRANULAR IGA IN DERMAL PAPILLAE IN DERMATITIS HERPETIFORMIS. LINEAR IGA IN LINEAR IGA DISEASE.
THE PATTERN ALONE OFTEN SETTLES THE DIAGNOSIS, WHICH IS WHY IT IS EXAMINED MORE THAN ANY OTHER INVESTIGATION IN THIS CHAPTER.
Salt-split skin
INCUBATION IN SODIUM CHLORIDE SPLITS SKIN THROUGH THE LAMINA LUCIDA. ANTIBODY ON THE ROOF MEANS BP180 OR BP230; ANTIBODY ON THE FLOOR MEANS TYPE VII COLLAGEN IN EPIDERMOLYSIS BULLOSA ACQUISITA.
IF THE TARGET LIES ABOVE THE LAMINA LUCIDA IT TRAVELS WITH THE ROOF; IF BELOW, IT STAYS WITH THE FLOOR. EBA RESPONDS POORLY TO TREATMENT THAT CONTROLS PEMPHIGOID.
Serology and monitoring
INDIRECT IMMUNOFLUORESCENCE AND ELISA DETECT CIRCULATING ANTIBODY, AND TITRES CORRELATE WITH DISEASE ACTIVITY IN PEMPHIGUS.
THIS MAKES SEROLOGY USEFUL FOR MONITORING RESPONSE AND PREDICTING RELAPSE, NOT ONLY FOR INITIAL DIAGNOSIS.
Rituximab first-line
THE RITUX 3 TRIAL SHOWED RITUXIMAB WITH SHORT-TERM PREDNISOLONE SUPERIOR TO PREDNISOLONE ALONE, WITH LONG-TERM FOLLOW-UP REPORTING SUSTAINED CORTICOSTEROID-FREE REMISSION.
THE MECHANISM FITS: PEMPHIGUS IS B-CELL DRIVEN, AND DEPLETING CD20-POSITIVE B CELLS REMOVES THE SOURCE OF ANTIBODY RATHER THAN SUPPRESSING INFLAMMATION.
Paraneoplastic pemphigus
SEVERE INTRACTABLE STOMATITIS WITH LICHENOID SKIN LESIONS, ASSOCIATED WITH LYMPHOPROLIFERATIVE DISEASE INCLUDING CLL AND CASTLEMAN DISEASE.
RESPIRATORY EPITHELIAL INVOLVEMENT PRODUCES BRONCHIOLITIS OBLITERANS, WHICH IS THE USUAL CAUSE OF DEATH AND IS NOT REVERSED BY TREATING THE SKIN.
Bullous pemphigoid targets
BP180, ALSO CALLED COLLAGEN XVII, IS TRANSMEMBRANE AND PATHOGENICALLY IMPORTANT. BP230 IS INTRACELLULAR. BOTH ARE HEMIDESMOSOMAL.
THE SPLIT IS BELOW THE ENTIRE EPIDERMIS, SO THE BLISTER ROOF IS FULL-THICKNESS SKIN AND THE BLISTERS ARE TENSE AND PERSISTENT.
The pemphigoid prodrome
INTENSE ITCH WITH URTICARIAL OR ECZEMATOUS PLAQUES CAN PRECEDE ANY BLISTER BY WEEKS OR MONTHS.
IT IS FREQUENTLY MISDIAGNOSED AS ECZEMA OR SCABIES, AND A NON-BULLOUS PHASE IS THE COMMONEST REASON FOR DELAYED DIAGNOSIS IN THE ELDERLY.
Gliptins and pemphigoid
DIPEPTIDYL PEPTIDASE-4 INHIBITORS CARRY THE HIGHEST DRUG-ASSOCIATED RISK OF BULLOUS PEMPHIGOID OF ANY DRUG CLASS, WITH VILDAGLIPTIN MOST STRONGLY IMPLICATED.
THIS MATTERS DISPROPORTIONATELY IN INDIA WHERE GLIPTINS ARE HEAVILY PRESCRIBED. DRUG-ASSOCIATED CASES OFTEN SHOW A NON-INFLAMMATORY PHENOTYPE, AND WITHDRAWAL ALONE CAN RESOLVE THE DISEASE.
Mucous membrane pemphigoid
IT SCARS. CONJUNCTIVAL DISEASE PRODUCES SYMBLEPHARON, ENTROPION, TRICHIASIS AND EVENTUALLY BLINDNESS.
OPHTHALMOLOGICAL REVIEW IS MANDATORY RATHER THAN OPTIONAL, BECAUSE THE SCARRING IS SILENT AND IRREVERSIBLE ONCE ESTABLISHED.
Dermatitis herpetiformis
THE SKIN EXPRESSION OF COELIAC DISEASE: INTENSELY ITCHY GROUPED VESICLES ON EXTENSORS AND BUTTOCKS, USUALLY EXCORIATED BEFORE THEY ARE SEEN, WITH GRANULAR IGA IN DERMAL PAPILLAE.
DAPSONE RELIEVES SYMPTOMS WITHIN DAYS BUT DOES NOTHING FOR THE ENTEROPATHY. A GLUTEN-FREE DIET TREATS THE DISEASE AND THE LONG-TERM LYMPHOMA RISK.
Removable triggers
GLIPTINS IN BULLOUS PEMPHIGOID, VANCOMYCIN IN LINEAR IGA DISEASE, GLUTEN IN DERMATITIS HERPETIFORMIS.
LOOK FOR A TRIGGER BEFORE COMMITTING TO LONG-TERM IMMUNOSUPPRESSION, BECAUSE REMOVING IT CAN MAKE IMMUNOSUPPRESSION UNNECESSARY.
Matching treatment to natural history
UNTREATED PEMPHIGUS WAS FATAL, SO IT JUSTIFIES IMMUNOSUPPRESSION WITH REAL RISK. PEMPHIGOID IS CHRONIC AND OFTEN REMITS, SO POTENT TOPICAL CORTICOSTEROID IS FREQUENTLY SUFFICIENT.
TRIAL DATA SHOW POTENT TOPICAL STEROID COMPARING WELL WITH SYSTEMIC STEROID IN PEMPHIGOID, WHICH IS COUNTERINTUITIVE GIVEN HOW DRAMATIC THE BLISTERS LOOK.
What actually kills in pemphigus
DENUDED SKIN LOSES FLUID, PROTEIN AND HEAT AND ADMITS BACTERIA, SO HISTORICAL MORTALITY CAME FROM SEPSIS AND METABOLIC DISTURBANCE RATHER THAN FROM THE BLISTERS.
NUTRITIONAL SUPPORT AND ANALGESIA FOR ORAL EROSIONS ARE TREATMENT RATHER THAN COMFORT MEASURES, AND IN INDIA PRE-IMMUNOSUPPRESSION SCREENING INCLUDES TUBERCULOSIS AND STRONGYLOIDES.
Toxic epidermal necrolysis versus pemphigus
BOTH HAVE A POSITIVE NIKOLSKY SIGN. TEN DEVELOPS OVER DAYS AFTER A DRUG WITH FULL-THICKNESS KERATINOCYTE NECROSIS; PEMPHIGUS DEVELOPS OVER WEEKS TO MONTHS WITH ACANTHOLYSIS.
MANAGEMENT IS OPPOSITE: WITHDRAW THE DRUG AND SUPPORT IN A BURNS SETTING, RATHER THAN IMMUNOSUPPRESS.
Staphylococcal scalded skin syndrome
EXFOLIATIVE TOXIN CLEAVES DESMOGLEIN 1, PRODUCING A SUBCORNEAL SPLIT IDENTICAL IN LEVEL TO PEMPHIGUS FOLIACEUS AND SPARING MUCOSA FOR THE SAME REASON.
IT IS A RARE INSTANCE OF A TOXIN AND AN AUTOANTIBODY PRODUCING AN IDENTICAL PICTURE THROUGH THE SAME MOLECULAR TARGET.
Blistering in children
BLISTERING FROM BIRTH OR EARLY INFANCY WITH A FAMILY HISTORY IS GENETIC UNTIL PROVED OTHERWISE. LATER ONSET IN AN OTHERWISE WELL CHILD IS MORE LIKELY INFECTIVE OR IMMUNOBULLOUS.
CHRONIC BULLOUS DISEASE OF CHILDHOOD GIVES THE STRING OF PEARLS APPEARANCE WITH LINEAR IGA AND RESPONDS TO DAPSONE.
⚠️

Traps NEET PG sets — and how to dodge them

These are the exact option-traps and misreads that cost marks under negative marking.

WATCH OUT
Memorising the diseases as antibody names rather than by split level
The level of the split predicts blister appearance, Nikolsky sign, mucosal involvement, patient age and untreated prognosis all at once. Reasoning from depth converts a list into a two-column table that can be reconstructed rather than recalled.
WATCH OUT
Taking direct immunofluorescence from the blister itself
The roof has already separated and its immunoreactants are lost, producing a false negative. Direct immunofluorescence is taken from perilesional skin, while histopathology is taken from an intact early blister; the two samples answer different questions.
WATCH OUT
Expecting mucosal disease in pemphigus foliaceus
Foliaceus antibodies target desmoglein 1 alone, and mucosa expresses abundant desmoglein 3 which compensates fully. Mucosal involvement effectively excludes foliaceus and points to pemphigus vulgaris or paraneoplastic pemphigus.
WATCH OUT
Excluding pemphigus vulgaris because the skin is normal
Mucosal-dominant disease with anti-desmoglein 3 alone produces oral erosions with entirely normal skin, sometimes for months, because desmoglein 1 compensates in the epidermis. Persistent unexplained oral erosions warrant biopsy.
WATCH OUT
Treating bullous pemphigoid as aggressively as pemphigus
Pemphigoid is chronic and often self-limiting over years, and trial data show potent topical corticosteroid comparing well with systemic steroid. Matching immunosuppression to natural history avoids unnecessary harm in an elderly, comorbid population.
WATCH OUT
Missing the non-bullous prodrome of pemphigoid
Intense itch with urticarial or eczematous plaques can precede blistering by weeks to months and is regularly labelled eczema or scabies. Persistent unexplained itch in an elderly patient warrants biopsy with direct immunofluorescence.
WATCH OUT
Not reviewing the drug list in an elderly patient with pemphigoid
Dipeptidyl peptidase-4 inhibitors carry the highest drug-associated risk of any class, vildagliptin most strongly, and they are very widely prescribed in India. Withdrawal alone can resolve the disease and avoid prolonged immunosuppression.
WATCH OUT
Treating mucous membrane pemphigoid without ophthalmology involvement
Conjunctival scarring produces symblepharon, entropion, trichiasis and blindness, and it progresses silently without prominent symptoms. Ophthalmological review is part of the diagnosis rather than a referral made when the eye becomes symptomatic.
WATCH OUT
Treating dermatitis herpetiformis with dapsone alone
Dapsone relieves itch within days but has no effect on the underlying gluten enteropathy or the associated small bowel lymphoma risk. A strict gluten-free diet treats the disease and eventually allows dapsone to be withdrawn.
WATCH OUT
Confusing granular and linear IgA deposition
Granular IgA in the dermal papillae indicates dermatitis herpetiformis, while linear IgA along the basement membrane indicates linear IgA disease. The pattern, not the immunoglobulin class, distinguishes them, and the associations differ entirely.
WATCH OUT
Diagnosing pemphigus from a positive Nikolsky sign alone
The sign is also positive in toxic epidermal necrolysis and staphylococcal scalded skin syndrome. Tempo and context separate them: days after a new drug suggests toxic epidermal necrolysis, and weeks to months with oral erosions suggests pemphigus.
WATCH OUT
Immunosuppressing a patient with toxic epidermal necrolysis
The mechanism is keratinocyte necrosis triggered by a drug, not autoantibody-mediated acantholysis. Management is immediate withdrawal of the culprit drug with supportive care in a burns or high-dependency setting, and histology settles the distinction.
WATCH OUT
Overlooking the underlying malignancy in paraneoplastic pemphigus
Severe intractable stomatitis with lichenoid lesions should prompt a search for lymphoproliferative disease including chronic lymphocytic leukaemia and Castleman disease. Bronchiolitis obliterans from respiratory epithelial involvement is the usual cause of death.
WATCH OUT
Starting immunosuppression without pre-treatment screening
Prolonged corticosteroid and rituximab require bone protection, glycaemic monitoring and infection risk assessment, and in India that includes screening for latent tuberculosis and strongyloidiasis before starting rather than after a complication.
WATCH OUT
Assuming all childhood blistering is infective
Onset from birth or early infancy with a family history suggests hereditary epidermolysis bullosa, in which autoantibody immunofluorescence is negative. Chronic bullous disease of childhood gives a string of pearls appearance with linear IgA and responds to dapsone.
WATCH OUT
Using serology only at diagnosis
Anti-desmoglein titres correlate with disease activity in pemphigus, so serial ELISA guides tapering and can predict relapse before it is clinically apparent. Treating it as a one-off confirmatory test wastes its most useful property.

Exam-pattern practice

PYQ-style questions with full solutions. Work through them as a readiness check — mark yourself honestly and get your gap report at the end.

Readiness check

Are you exam-ready for "Immunobullous Disorders"?

9 problems from this chapter. Try each one, reveal the worked solution, mark yourself honestly — get your gap report at the end.

9 questions~6 min

5-minute revision

The whole chapter, distilled. Read this the night before the exam.

  • Ask at what level the skin splits; everything follows.
  • Desmosomes hold keratinocytes together within the epidermis.
  • Hemidesmosomes anchor epidermis to dermis.
  • Intraepidermal split gives flaccid blisters and a positive Nikolsky sign.
  • Subepidermal split gives tense blisters and a negative Nikolsky sign.
  • Pemphigus involves mucosa; pemphigoid usually spares it.
  • Pemphigus affects middle age; pemphigoid affects the elderly.
  • Untreated pemphigus was fatal; pemphigoid is chronic.
  • Dsg3 dominates mucosa and deep epidermis.
  • Dsg1 dominates superficial epidermis and is weak in mucosa.
  • Anti-Dsg3 alone gives mucosal-dominant pemphigus vulgaris.
  • Anti-Dsg3 plus anti-Dsg1 gives mucocutaneous disease.
  • Anti-Dsg1 alone gives pemphigus foliaceus with no mucosal disease.
  • Pemphigus vulgaris splits suprabasally with a tombstone row.
  • Pemphigus foliaceus splits subcorneally.
  • Nikolsky sign shears apparently normal skin.
  • Asboe-Hansen sign extends an existing blister under pressure.
  • Histology is taken from an intact early blister.
  • Direct immunofluorescence is taken from perilesional skin.
  • Pemphigus shows fishnet intercellular IgG and C3.
  • Pemphigoid shows linear IgG and C3 at the basement membrane.
  • Dermatitis herpetiformis shows granular IgA in dermal papillae.
  • Linear IgA disease shows linear IgA at the basement membrane.
  • Anti-desmoglein titres track disease activity in pemphigus.
  • Pemphigus foliaceus endemic form is fogo selvagem.
  • Paraneoplastic pemphigus causes intractable stomatitis.
  • It associates with CLL and Castleman disease.
  • Bronchiolitis obliterans is the usual cause of death in it.
  • Rituximab is now first-line in pemphigus vulgaris.
  • Ritux 3 showed superiority over prednisolone alone.
  • Rituximab depletes CD20-positive B cells producing the antibody.
  • First-line rituximab reduces cumulative steroid exposure.
  • Bullous pemphigoid is the commonest immunobullous disease.
  • Targets are BP180 (collagen XVII) and BP230.
  • BP180 is transmembrane and pathogenically important.
  • An itchy urticarial prodrome can last months before blisters.
  • Potent topical steroid compares well with systemic steroid in pemphigoid.
  • Gliptins carry the highest drug-associated pemphigoid risk.
  • Vildagliptin is most strongly implicated.
  • Drug-associated cases often show a non-inflammatory phenotype.
  • Mucous membrane pemphigoid scars and can blind.
  • Symblepharon, entropion and trichiasis follow conjunctival disease.
  • Pemphigoid gestationis starts periumbilically in the third trimester.
  • It can cause transient neonatal blistering via transplacental antibody.
  • Dermatitis herpetiformis is the skin expression of coeliac disease.
  • Dapsone relieves symptoms within days.
  • A gluten-free diet treats the enteropathy and lymphoma risk.
  • Linear IgA disease in adults is often vancomycin-induced.
  • Epidermolysis bullosa acquisita targets type VII collagen.
  • Salt-split skin puts pemphigoid antibody on the roof.
  • It puts epidermolysis bullosa acquisita antibody on the floor.
  • Match treatment aggression to natural history.
  • Look for a removable trigger before long-term immunosuppression.
  • Historical pemphigus mortality was from sepsis and fluid loss.
  • Oral erosions require nutritional support and analgesia.
  • Screen for tuberculosis and strongyloidiasis before immunosuppression in India.
  • Toxic epidermal necrolysis also has a positive Nikolsky sign.
  • It develops over days after a drug, with necrosis not acantholysis.
  • Staphylococcal scalded skin syndrome cleaves desmoglein 1.
  • It spares mucosa because desmoglein 3 compensates there.
  • Chronic bullous disease of childhood shows a string of pearls.
  • Hereditary epidermolysis bullosa has negative autoantibody studies.
  • Blistering from birth with a family history is genetic until disproved.

NEET PG question blueprint

How this topic is asked, tier by tier — so you can prep to the pattern.

Typical weightage: Each NEET PG question is worth +4/-1; immunobullous disorders contribute 4-5 questions per attempt and overlap with Pathology, Medicine and Ophthalmology

Question styleMarks eachTypical countWhat it tests
Level of split4~1Blister character, Nikolsky sign and prognosis predicted from depth
Desmoglein compensation4~1Antibody profile predicting mucosal versus cutaneous involvement
Pemphigus4~1Presentation, histology, immunofluorescence and variants including paraneoplastic disease
Bullous pemphigoid4~1Target antigens, the prodrome, and the gliptin association
Immunofluorescence4~1Pattern recognition across the group and the salt-split technique
Dermatitis herpetiformis4~1Distribution, granular IgA and the two components of treatment
Treatment principles4~1Rituximab first-line evidence, matching intensity to natural history, and removable triggers
Differential diagnosis4~1Toxic epidermal necrolysis, staphylococcal scalded skin syndrome and paediatric blistering

Exam-hall strategy

Battle-tested tips from mentors and toppers for this topic under the sectional clock.

  1. Read blister character and Nikolsky sign first; they give the level of the split.
  2. Check whether mucosa is involved; it separates pemphigus from pemphigoid and vulgaris from foliaceus.
  3. For immunofluorescence stems, distinguish pattern before immunoglobulin class.
  4. Note the patient's age; pemphigoid is a disease of the elderly.
  5. Scan the drug history for gliptins and vancomycin.
  6. For rapid onset after a drug, think toxic epidermal necrolysis, not pemphigus.
  7. In children, onset from birth points to hereditary disease.
  8. With NEET PG's +4/-1 marking, the two-column split table, immunofluorescence patterns and desmoglein distribution are high-certainty recall worth banking early.
  9. Under the 5-group, 42-minute time-bound format, clear those fast and spend the remaining time on the compensation and treatment-principle stems, since a closed group cannot be reopened.

Beyond the exam

Where this skill shows up in the job you're competing for — and in life.

Biopsying the itchy elderly patient

Taking a biopsy with direct immunofluorescence in an older patient with unexplained persistent itch catches bullous pemphigoid during its non-bullous prodrome, months before anyone reaches the diagnosis clinically.

Reading the drug chart before the slide

Checking whether a new pemphigoid patient is on a gliptin can make the difference between stopping one tablet and starting long-term immunosuppression in a frail diabetic.

Sending the mouth ulcer for immunofluorescence

Persistent oral erosions that will not heal are how pemphigus vulgaris presents, often months before any skin lesion, and a perilesional biopsy is what shortens that delay.

Referring the eye before it scars

Ophthalmological review at diagnosis in mucous membrane pemphigoid detects conjunctival scarring while it is still reversible in its effects, since symblepharon and trichiasis are silent until sight is already compromised.

Where else this topic is tested

Prepare once, score in every exam that asks it.

FMGE / NExTVery high overlap — pemphigus versus pemphigoid, immunofluorescence patterns and dermatitis herpetiformis are examined at identical depth
USMLE Step 2 CKHigh overlap — the same core distinctions are tested, with more emphasis on drug-induced disease and less on regional prescribing patterns
MD Dermatology and DNB entranceFoundational — assumed working knowledge, with antigen mapping, immunopathology and biologic therapy examined far more deeply

Questions aspirants ask

Pulled from the Q&A community and mentor sessions.

Because the depth of separation determines the mechanical properties of the blister, and those properties are what the clinician actually observes. When autoantibodies attack desmogleins, adhesion fails between keratinocytes within the epidermis, so the blister roof consists of only a few cell layers. That roof has almost no tensile strength, so blisters rupture within hours and the patient presents with erosions rather than intact bullae, and lateral pressure on adjacent skin shears it away because acantholysis extends beyond the visible lesion, which is the Nikolsky sign. When autoantibodies attack hemidesmosomal proteins, the separation occurs beneath the entire epidermis, so the roof is full-thickness skin including the stratum corneum. That roof is tough, so blisters remain intact for days, can become large and tense, and adjacent skin does not shear, giving a negative Nikolsky sign. The depth also predicts mucosal involvement indirectly, because mucosal epithelium expresses the desmosomal targets abundantly and the hemidesmosomal targets in a distribution that produces less blistering. And it predicts prognosis, since widespread loss of epidermal cohesion produces the fluid, protein and heat loss that made untreated pemphigus fatal, while a subepidermal disease with intact blisters produces far less physiological disturbance.

Because it acts on the source of the disease rather than on its consequences, and the trial evidence turned out to be unusually clear-cut. Pemphigus is driven by autoantibodies produced by a specific population of B cells, so suppressing inflammation with corticosteroid controls the effect while leaving the antibody-producing cells intact. That is why conventional treatment required prolonged high-dose steroid, why relapse on tapering was common, and why cumulative toxicity, including diabetes, osteoporosis, avascular necrosis, myopathy and serious infection, accounted for much of the morbidity and some of the mortality. Rituximab depletes CD20-positive B cells, removing the precursors of the antibody-secreting plasmablasts, and because that population must be regenerated, remission can outlast the drug itself. The Ritux 3 trial compared rituximab plus short-term prednisolone against prednisolone alone as first-line therapy and found the combination superior, and long-term follow-up published subsequently reported sustained corticosteroid-free remission in a substantial proportion of the rituximab arm. The practical consequence is not only better disease control but markedly lower cumulative steroid exposure. It is not risk-free: rituximab requires screening for hepatitis B reactivation, latent tuberculosis and, in Indian practice, strongyloidiasis, and it causes hypogammaglobulinaemia with repeated courses.

Because the association is the strongest of any drug class, and the exposed population in India is enormous. Dipeptidyl peptidase-4 inhibitors have been linked to bullous pemphigoid in multiple large epidemiological studies, with vildagliptin most strongly implicated, and the risk is substantially higher than for any other drug group. The proposed mechanism involves dipeptidyl peptidase-4 being expressed on immune cells and involved in the processing of chemokines and in plasmin-mediated cleavage of BP180, so inhibiting it alters the immunogenicity of the target antigen. Drug-associated cases frequently show a distinctive phenotype with less erythema and inflammation than classical pemphigoid, and antibodies directed at different BP180 epitopes, which means they can look atypical and be missed. The Indian relevance is a matter of prescribing volume. Gliptins are among the most widely used oral hypoglycaemics in the country because they are weight-neutral, carry little hypoglycaemia risk and are available cheaply as generics, so a very large number of elderly diabetics are exposed. Since withdrawal alone can lead to resolution, reviewing the drug is potentially curative and avoids committing a frail patient to prolonged immunosuppression. The practical rule is simple: any elderly diabetic on a gliptin who develops unexplained itch or blistering has the drug reviewed.

Because dapsone treats the skin and the disease is in the gut. Dermatitis herpetiformis is the cutaneous manifestation of gluten sensitivity. Ingested gluten drives an IgA response against tissue transglutaminase, and cross-reactive antibodies against epidermal transglutaminase deposit granularly in the dermal papillae, where they recruit neutrophils and produce the intensely itchy vesicles on extensor surfaces. Dapsone works downstream of all of that by inhibiting neutrophil function, principally through effects on myeloperoxidase and neutrophil chemotaxis, so it suppresses the inflammatory response within days, sometimes within hours. Patients find the relief dramatic, which is precisely the problem, because it makes dietary restriction feel unnecessary. But dapsone does nothing about the gluten-driven enteropathy, which continues to cause malabsorption, iron and folate deficiency, osteoporosis and, over decades, an increased risk of small bowel lymphoma. It also carries its own burden, including dose-dependent haemolysis, methaemoglobinaemia, agranulocytosis and a hypersensitivity syndrome, so indefinite use is undesirable. A strict gluten-free diet addresses the cause, and although the skin responds slowly over months, adherence eventually allows dapsone to be reduced and stopped.

Because both attack the same molecule, one with an antibody and one with a bacterial enzyme, and the molecule's distribution determines everything that follows. Certain strains of Staphylococcus aureus produce exfoliative toxins A and B, which are serine proteases with an extremely narrow substrate specificity: they cleave desmoglein 1 and essentially nothing else. Pemphigus foliaceus antibodies bind and disable the same protein. Since desmoglein 1 is expressed most strongly in the superficial epidermis, both conditions produce a subcorneal split, giving flaccid superficial blisters that rupture to leave superficial scaling and erosions, most prominently in flexures and around orifices, with a positive Nikolsky sign. Both also spare mucosal surfaces, for exactly the same reason, which is that mucosa expresses abundant desmoglein 3 that fully compensates for loss of the small amount of desmoglein 1 present. This is a rare and instructive convergence in dermatology: a toxin and an autoantibody produce clinically indistinguishable disease because they share a molecular target. What separates them is context and tempo. Scalded skin syndrome affects young children or immunocompromised adults, evolves over a day or two with fever and a distant staphylococcal focus, and resolves with antistaphylococcal antibiotics, while pemphigus foliaceus is indolent and requires immunosuppression.
Header Logo